{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:57:13Z","timestamp":1793721433648,"version":"4.6.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR003017"],"award-info":[{"award-number":["UL1TR003017"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23DA053989"],"award-info":[{"award-number":["K23DA053989"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001774","name":"New Jersey Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine Reports"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.pmedr.2023.102374","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T07:40:27Z","timestamp":1692430827000},"page":"102374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Overdose education and naloxone distribution program design informed by people who use drugs and naloxone distributors"],"prefix":"10.1016","volume":"35","author":[{"given":"Michael","family":"Enich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Flumo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Netanya","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Mellor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amesika N.","family":"Nyaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pmedr.2023.102374_b0005","unstructured":"Agency for Healthcare Research and Quality. Using Community-Based Participatory Research to Address Health Care Disparities. Published September 1, 2012. Accessed April 4, 2021. http:\/\/www.ahrq.gov\/research\/findings\/factsheets\/minority\/cbprbrief\/index.html."},{"issue":"S1","key":"10.1016\/j.pmedr.2023.102374_b0010","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.2105\/AJPH.2018.304730","article-title":"Designing and assessing multilevel interventions to improve minority health and reduce health disparities","volume":"109","author":"Agurs-Collins","year":"2019","journal-title":"Am. J. Public Health"},{"issue":"1","key":"10.1016\/j.pmedr.2023.102374_b0015","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1080\/07853890.2022.2121418","article-title":"Evaluating the impact of naloxone dispensation at public health vending machines in Clark County, Nevada","volume":"54","author":"Allen","year":"2022","journal-title":"Ann. Med."},{"key":"10.1016\/j.pmedr.2023.102374_b0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.drugalcdep.2018.05.023","article-title":"Characterizing peer roles in an overdose crisis: Preferences for peer workers in overdose response programs in emergency shelters","volume":"190","author":"Bardwell","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pmedr.2023.102374_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2016.01.003","article-title":"Peer-Delivered Recovery Support Services for Addictions in the United States: A Systematic Review","volume":"63","author":"Bassuk","year":"2016","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.pmedr.2023.102374_b0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ypmed.2018.06.005","article-title":"Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review","volume":"114","author":"Behar","year":"2018","journal-title":"Prev. Med."},{"issue":"3","key":"10.1016\/j.pmedr.2023.102374_b0035","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/02791072.2018.1430409","article-title":"From Peers to Lay Bystanders: Findings from a Decade of Naloxone Distribution in Pittsburgh","volume":"50","author":"Bennett","year":"2018","journal-title":"PA. J Psychoactive Drugs."},{"issue":"1","key":"10.1016\/j.pmedr.2023.102374_b0040","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-017-0145-2","article-title":"Expanding conceptualizations of harm reduction: results from a qualitative community-based participatory research study with people who inject drugs","volume":"14","author":"Boucher","year":"2017","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.pmedr.2023.102374_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2019.112384","article-title":"The intersectional risk environment of people who use drugs","volume":"234","author":"Collins","year":"2019","journal-title":"Soc Sci Med"},{"issue":"180","key":"10.1016\/j.pmedr.2023.102374_b0050","first-page":"20","article-title":"The social logic of naloxone: Peer administration, harm reduction, and the transformation of social policy","volume":"2017","author":"Faulkner-Gurstein","year":"1982","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.pmedr.2023.102374_b0055","first-page":"22","article-title":"Toward addressing social determinants of health: A health care system strategy","author":"Friedman","year":"2018","journal-title":"Perm. J."},{"issue":"1","key":"10.1016\/j.pmedr.2023.102374_b0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12954-019-0352-0","article-title":"Preventing opioid overdose with peer-administered naloxone: findings from a rural state","volume":"17","author":"Hanson","year":"2020","journal-title":"Harm Reduct. J."},{"issue":"4","key":"10.1016\/j.pmedr.2023.102374_b0065","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/1049732316665344","article-title":"Code Saturation Versus Meaning Saturation: How Many Interviews Are Enough?","volume":"27","author":"Hennink","year":"2017","journal-title":"Qual. Health Res."},{"issue":"11","key":"10.1016\/j.pmedr.2023.102374_b0070","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2105\/AJPH.2009.170506","article-title":"Community-based participatory research: A capacity-building approach for policy advocacy aimed at eliminating health disparities","volume":"100","author":"Israel","year":"2010","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.pmedr.2023.102374_b0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.drugpo.2018.02.008","article-title":"Effects of naloxone distribution to likely bystanders: Results of an agent-based model","volume":"55","author":"Keane","year":"2018","journal-title":"Int. J. Drug Policy"},{"issue":"1","key":"10.1016\/j.pmedr.2023.102374_b0080","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13722-016-0068-3","article-title":"Opioid overdose prevention and naloxone rescue kits: what we know and what we don\u2019t know","volume":"12","author":"Kerensky","year":"2017","journal-title":"Addict. Sci. Clin. Pract."},{"issue":"8","key":"10.1016\/j.pmedr.2023.102374_b0085","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1080\/10826084.2020.1735437","article-title":"\u201cA Blessing and a Curse:\u201d Opioid Users\u2019 perspectives on naloxone and the epidemic of opioid overdose","volume":"55","author":"Kline","year":"2020","journal-title":"Subst. Use Misuse"},{"issue":"1","key":"10.1016\/j.pmedr.2023.102374_b0090","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.drugalcdep.2003.09.005","article-title":"Social network correlates of self-reported non-fatal overdose","volume":"73","author":"Latkin","year":"2004","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.pmedr.2023.102374_b0095","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-7517-11-26","article-title":"Establishing a community-based participatory research partnership among people who use drugs in Ottawa: the PROUD cohort study","volume":"11","author":"Lazarus","year":"2014","journal-title":"Harm Reduct. J."},{"issue":"7","key":"10.1016\/j.pmedr.2023.102374_b0100","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2105\/AJPH.2016.303141","article-title":"Evaluation of the overdose education and naloxone distribution program of the baltimore student harm reduction coalition","volume":"106","author":"Lewis","year":"2016","journal-title":"Am. J. Public Health"},{"issue":"1","key":"10.1016\/j.pmedr.2023.102374_b0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12954-022-00599-4","article-title":"How do naloxone-based interventions work to reduce overdose deaths: a realist review","volume":"19","author":"Miller","year":"2022","journal-title":"Harm Reduct. J."},{"issue":"1","key":"10.1016\/j.pmedr.2023.102374_b0110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12954-017-0160-3","article-title":"Naloxone and the Inner City Youth Experience (NICYE): a community-based participatory research study examining young people\u2019s perceptions of the BC take home naloxone program","volume":"14","author":"Mitchell","year":"2017","journal-title":"Harm Reduct. J."},{"issue":"2","key":"10.1016\/j.pmedr.2023.102374_b0115","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/08897077.2015.1010032","article-title":"A review of opioid overdose prevention and naloxone prescribing: implications for translating community programming into clinical practice","volume":"36","author":"Mueller","year":"2015","journal-title":"Subst Abuse."},{"key":"10.1016\/j.pmedr.2023.102374_b0120","unstructured":"National Institute on Minority Health & Health Disparities. Community-Based Participatory Research Program (CBPR). NIMHD. Accessed April 15, 2021. https:\/\/www.nimhd.nih.gov\/programs\/extramural\/community-based-participatory.html."},{"key":"10.1016\/j.pmedr.2023.102374_b0125","doi-asserted-by":"crossref","unstructured":"Padgett D. Qualitative and Mixed Methods in Public Health. SAGE Publications, Inc.; 2012. doi:10.4135\/9781483384511.","DOI":"10.4135\/9781483384511"},{"issue":"3","key":"10.1016\/j.pmedr.2023.102374_b0130","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/1468-0009.12470","article-title":"Situating the Continuum of Overdose Risk in the Social Determinants of Health: A New Conceptual Framework","volume":"98","author":"Park","year":"2020","journal-title":"Milbank Q."},{"key":"10.1016\/j.pmedr.2023.102374_b0135","series-title":"Qualitative Research & Evaluation Methods","author":"Patton","year":"2020"},{"issue":"2","key":"10.1016\/j.pmedr.2023.102374_b0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0955-3959(02)00007-5","article-title":"The \u2018risk environment\u2019: a framework for understanding and reducing drug-related harm","volume":"13","author":"Rhodes","year":"2002","journal-title":"Int. J. Drug Policy"},{"issue":"1","key":"10.1016\/j.pmedr.2023.102374_b0145","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/add.15163","article-title":"Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States","volume":"116","author":"Smart","year":"2021","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.pmedr.2023.102374_b0150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.drugalcdep.2006.08.002","article-title":"The association between change in social network characteristics and non-fatal overdose: Results from the SHIELD study in Baltimore, MD, USA","volume":"87","author":"Tobin","year":"2007","journal-title":"Drug Alcohol Depend."},{"issue":"6","key":"10.1016\/j.pmedr.2023.102374_b0155","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care J Int Soc Qual Health Care."},{"issue":"1-2","key":"10.1016\/j.pmedr.2023.102374_b0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/10826084.2012.720335","article-title":"Personal Social Network Factors Associated with Overdose Prevention Training Participation","volume":"48","author":"Wagner","year":"2013","journal-title":"Subst. Use Misuse"},{"issue":"jan30 5","key":"10.1016\/j.pmedr.2023.102374_b0165","doi-asserted-by":"crossref","first-page":"f174","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis","volume":"346","author":"Walley","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.pmedr.2023.102374_b0170","unstructured":"Wheeler E, Jones S, Gilbert M. Opioid Overdose Prevention Programs Providing Naloxone to Laypersons. Accessed April 4, 2021. https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6423a2.htm."},{"issue":"1","key":"10.1016\/j.pmedr.2023.102374_b0175","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-020-02923-3","article-title":"The effectiveness of one-to-one peer support in mental health services: a systematic review and meta-analysis","volume":"20","author":"White","year":"2020","journal-title":"BMC Psychiatry"},{"issue":"4","key":"10.1016\/j.pmedr.2023.102374_b0180","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2105\/AJPH.2020.306124","article-title":"NEXT harm reduction: an online, mail-based naloxone distribution and harm-reduction program","volume":"111","author":"Yang","year":"2021","journal-title":"Am. J. Public Health"}],"container-title":["Preventive Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211335523002656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211335523002656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T03:54:04Z","timestamp":1732679644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211335523002656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":36,"alternative-id":["S2211335523002656"],"URL":"https:\/\/doi.org\/10.1016\/j.pmedr.2023.102374","relation":{},"ISSN":["2211-3355"],"issn-type":[{"value":"2211-3355","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overdose education and naloxone distribution program design informed by people who use drugs and naloxone distributors","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmedr.2023.102374","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102374"}}